Publicaciones en las que colabora con Jesús Egido de los Ríos (69)

2022

  1. The Synthetic Flavonoid Hidrosmin Improves Endothelial Dysfunction and Atherosclerotic Lesions in Diabetic Mice

    Antioxidants, Vol. 11, Núm. 12

2014

  1. IL-17A is a novel player in dialysis-induced peritoneal damage

    Kidney International, Vol. 86, Núm. 2, pp. 303-315

2013

  1. Eplerenone enhances cardioprotective effects of standard heart failure therapy through matricellular proteins in hypertensive heart failure

    Journal of Hypertension, Vol. 31, Núm. 11, pp. 2309-2319

  2. Gremlin is a downstream profibrotic mediator of transforming growth factor-beta in cultured renal cells

    Nephron - Experimental Nephrology, Vol. 122, Núm. 1-2, pp. 62-74

  3. TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and Ras-dependent proliferation of cultured renal fibroblast

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1832, Núm. 10, pp. 1744-1755

2012

  1. Angiotensin II contributes to renal fibrosis independently of notch pathway activation

    PLoS ONE, Vol. 7, Núm. 7

2010

  1. Local non-esterified fatty acids correlate with inflammation in atheroma plaques of patients with type 2 diabetes

    Diabetes, Vol. 59, Núm. 6, pp. 1292-1301

  2. Obstructive renal injury: From fluid mechanics to molecular cell biology

    Open Access Journal of Urology, Vol. 2, Núm. 1, pp. 41-55

  3. Regulation of vascular and renal cells by common mediators in health and disease: Role of the renin-angiotensin system in the pathophysiology of hypertension and cardiovascular disease

    Cardiorenal Syndrome: Mechanisms, Risk and Treatment (Springer Milan), pp. 49-63

  4. Statins inhibit angiotensin II/smad pathway and related vascular fibrosis, by a TGF-β-independent process

    PLoS ONE, Vol. 5, Núm. 11

  5. TNF superfamily: A growing saga of kidney injury modulators

    Mediators of Inflammation, Vol. 2010

  6. Unravelling fibrosis: Two newcomers and an old foe

    Nephrology Dialysis Transplantation, Vol. 25, Núm. 11, pp. 3492-3495

2009

  1. A nanoconjugate Apaf-1 inhibitor protects mesothelial cells from cytokine-induced injury

    PLoS ONE, Vol. 4, Núm. 8

  2. CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-κB

    Journal of the American Society of Nephrology, Vol. 20, Núm. 7, pp. 1513-1526

  3. La transcriptómica ilustra nuevas vías letales en la nefropatía diabética

    Nefrologia, Vol. 29, Núm. 1, pp. 13-19

  4. Taming apoptosis in peritoneal dialysis

    Peritoneal Dialysis International

  5. Transcriptome of hypertension-induced left ventricular hypertrophy and its regression by antihypertensive therapies

    Hypertension Research, Vol. 32, Núm. 5, pp. 347-357

2008

  1. 3,4-Dideoxyglucosone-3-ene as a mediator of peritoneal demesothelization

    Nephrology Dialysis Transplantation, Vol. 23, Núm. 10, pp. 3307-3315

  2. Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation

    Kidney International, Vol. 74, Núm. 5, pp. 585-595

  3. Bcl-xL prevents peritoneal dialysis solution-induced leukocyte apoptosis

    Peritoneal Dialysis International, Vol. 28, Núm. SUPPL. 5